Reversal of fatty infiltration of pennate rotator cuff muscle after tendon release is hitherto impossible. The administration of nandrolone starting at the time of tendon release prevents the increase in fat content, but does not revert established fatty infiltration.
1. Introduction
Degeneration and repair of the ruptured rotator cuff muscle
Tears of rotator cuff tendons affect a considerable portion of the elderly population [1, 2] . Tendon tears lead to musculotendinous retraction, which is associated with muscle transformation by a progressive increase in fat and connective tissue content at the expense of contractile material (fatty infiltration; [3] [4] [5] ). Even if surgical repair is successful, this transformation of muscle structure is hitherto irreversible (reviewed in [4] ) and thereby interferes with restoration of muscle function. The infiltration of muscle with fat tissue is such a risk factor for the success of tendon repair, that an increase in fat content close to, or above 50% of total muscle volume is considered a contra-indication for surgical repair [6] . Muscular changes may render successful reattachment of the ruptured tendon impossible (reviewed in Ref. [4] ), due to shortening and stiffening of the detached and atrophic muscle. Thus the prevention of muscular transformation in the retracted muscle is a high priority to allow successful repair of the musculotendinous unit after tendon tear.
Anabolic steroids prevent fat accumulation and increase lean mass
Anabolic steroids are a proposed treatment against the accumulation of fat and associated muscle atrophy [5] because they increase lean over fat mass by promoting muscle anabolism and reducing fat content [7] [8] [9] . We recently reported that the anabolic steroid nandrolone decanoate can prevent the increase in fat content, but does not mitigate atrophy of rotator cuff muscle in sheep and rabbit models if administered at the time of tendon release [10, 11] . Anabolic steroids affect a number of systemic and local aspects of lipid metabolism, which may be implicated in fat accumulation in tenotomized rotator cuff muscle. Anabolic steroids reduce lipogenic activity in the liver [12] and enhance lipolytic activity in adipose tissue [13] . Furthermore, anabolic steroids inhibit adipocyte differentiation and affect skeletal muscle directly through genomic effects on transcript expression being associated with cell growth and proliferation, connective tissue development and function as shown in rat experiments [13] [14] [15] [16] [17] . Tenotomy has been demonstrated to increase phospholipid and triglyceride content in rat skeletal muscle, which has been postulated to involve the infiltration and expansion of adipogenic cells, as well as de-differentiation of muscle-associated stem cells or fibroblast into adipocytes [18] [19] [20] [21] [22] . This raises the possibility that nandrolone prevents fat accumulation in tenotomized muscle [10, 11] by multiple mechanisms in skeletal muscle including the abrogation of phospholipid and triglyceride synthesis, the enhancement of lipid oxidation [23, 24] , through effects on adipocyte differentiation and/or expression of adipogenic pathways in skeletal muscle.
Ruptured rotator cuff muscle looses responsiveness to nandrolone
Interestingly, nandrolone does not influence fat accumulation in rotator cuff muscle in sheep and rabbit models of tendon release if administered after muscle degeneration has established [10, 11] . This biological fact imposes possible limitations for full improvement of muscle function if repair of the tendon is delayed [25, 26] . The main cytoplasmic receptor of anabolic steroids, the androgen receptor [17, 27] , is abundantly expressed in skeletal muscle. In the rat androgen receptor expression is sensitive to muscle loading and also to circulating hormone levels, i.e. being reduced with unloading and increased with nandrolone [28, 29] . This suggests that the loss in responsiveness of rotator cuff muscle to anabolic steroids after tendon tear in sheep [30] involves changes in androgen receptor-mediated gene regulation.
Aim and hypotheses
The purpose of this study was to investigate 1) whether a musclebased molecular mechanism underlies the increased fat content in sheep infraspinatus muscle 16 weeks after tendon release and 2) whether expression changes explain its mitigationwhen nandrolone is administered immediately after tendon release before fatty infiltration is established. As metabolism related targets of nandrolone action in skeletal muscle are not established, we first carried out a global assessment of lipid and transcript expression changes with tendon release and repair. For this purpose, we assessed to which extent alterations in transcript expression in detached infraspinatus muscle are suppressed by weekly injections of nandrolone, and whether the transcript response differs when nandrolone is administered immediately after tendon release or only after repair, and whether the response is related to androgen receptor levels. We specifically hypothesised that tendon release enhances transcript expression for gene ontologies (GOs) regulating adipocyte differentiation and lipid metabolism and associated lipid species in detached infraspinatus muscle, and that nandrolone down-regulates this expression program.
Materials and method

Experimental design
Eighteen female Swiss Alpine sheep (two years old; provider Staffelegg, Küttigen (AG), Switzerland) were subjected to release of the infraspinatus tendon in three interventional groups of six animals each (CONTROL: 45.3 AE 1.9 kg, N22W: 47.1 AE 0.8 kg, N6W: 48.4 AE 1.5 kg). N22W received weekly injections of 150 mg nandrolone decanoate (Deca-Durabolin 1 ) into the gluteus maximus muscle in the post-operative phase starting immediately after tendon release. N6W received weekly intramuscular injections of 150 mg nandrolone decanoate starting at the time of tendon repair, i.e. after 16 weeks. At 16 weeks, repair was performed in all groups by a single stage repair of the tendon to the greater tuberosity. Prior to tendon release (PRE), 16 weeks after tendon release (TR) and 6 weeks after repair (END) measurements were made on the operated muscle to characterize retraction, volume and fat content of the infraspinatus muscle. The measures were compared to contralateral control muscle at the end of the experiment (END-CC). Further, biopsy samples from the infraspinatus muscle were collected. Biopsies were subjected to the characterization of muscle composition and transcript expression. Absolute values for the volumetric and cellular adjustments of infraspinatus muscle have in part been reported. They are now included as percentage change to allow the interpretation of the new measurements on molecular parameters with tendon release and repair. The experiment was approved by the local federal authorities (Veterinary Office of the Canton of Zurich, application number 72/2013).
Tendon release and reattachment
All procedures were carried out on the right shoulder essentially as described [4, 30] . The tendon was released by osteotomy of the greater tuberosity (20 Â 10 Â 10 mm) using an oscillating saw. The tendon stump was grasped via its attached bone chip through 2 figure-of-8 stitches using Fiberwire USP No. 2 sutures (Arthrex, Inc, Naples, Florida) that passed within a 1.8-mm drill-hole in the bone chip. Subsequently, the tendon and bone chip, with the tied sutures, were wrapped in a silicon tube (Silicone Penrose drain tube, 12 mm diameter; Fortune Medical Instrument, Taipei, Taiwan) to prevent reattachment through scar tissue. Sixteen weeks later, rotator cuff repair was performed. The bone chip was reattached to its original site, or as near as possible by connecting the remaining sutures to a 3.5-mm self-tapping cortical bone screw (Synthes, Paoli, USA) with a washer. During the first three weeks of the rehabilitation period, stress to the repaired tendon was eased by reducing full weight bearing through suspension of the sheep in a loose belt and by attaching a ball to the claws. After 6 weeks of reattachment, the animals were sacrificed.
Muscle anatomy
Immediately after each surgical intervention, magnetic resonance imaging (MRI) and computed tomography of both shoulders was performed with the animal still under general anesthesia. MRI scans were evaluated for bone chip retraction, muscle volume using a Digital Imaging and Communications in Medicine (DICOM) viewer (OsiriX v.5.6 32-bit) as described [11] .
Sampling of muscle tissue
Biopsies were harvested during each of the surgical interventions from the middle portion of the lateral compartment of the operated infraspinatus muscle. This was achieved via Bergstroem biopsy needles with a 5-mm diameter (Dixons Surgical Instruments LTD, Wickford, UK) through a 15-cm curved incision 2 cm caudal to the scapular spine. Biopsy samples were rapidly dissected free of excessive connective tissue and blood, frozen in melting isopentane and kept individually in sealed 2-mL cryotubes (Greiner, Frickenhausen, Germany) at À80 C until use. At the time point of sacrifice, the entire infraspinatus muscle and its contralateral control, were excised under general anesthesia and frozen at À80 C.
Characterization of muscle composition (morphometry)
Immunohistochemical detection and morphometric quantification of muscle fibers, lipid droplets and extracellular matrix was carried out essentially as described using cryosections [11, 31] . In brief, cryosections were prepared at 12-mm thickness perpendicularly to the major axis of muscle fibers within the biopsy. Sections were stored at À80 C until being processed using the Goldner trichome method to distinguish contractile from connective tissue, and Red Oil O staining to detect lipid. The stained sections were digitally recorded using an IX50 microscope with a digital camera DP72 (Olympus Schweiz AG) that was operated with the Cell Sens Dimension software (Version 1.6, Olympus Corporation). Images were exported as tiff-file into Adobe Photoshop CC (Adobe Systems Incorporated) or ImageJ software (http://rsbweb. nih.gov/ij/). Goldner trichome stained sections were analyzed using the lasso tool for the area percentage of muscle fibers (red structures) and connective tissue (green and non-stained structures). Lipid content was assessed in Red Oil O stained sections from the red signal using a macro with imageJ software (http:// rsbweb.nih.gov/ij/). Numbers from the different fields were summed for the respective cellular structures to calculate the respective area percentages of muscle fibers, lipid and extracellular matrix for the entire cross section/biopsy. The percentage of extracellular matrix was calculated as the difference between the respective area percentage of connective tissue (as estimated from the Goldner staining) and lipid (as estimated in the Red Oil O staining).
Lipidome analysis
Lipid species were analyzed in infraspinatus muscle samples using ultrahigh performance liquid chromatography-tandem mass spectrometry coupled by nano electrospray source ionization (UPLC-nanoESI-MSMS) based on established protocols [6, 32] and SOPs for lipid analysis of the FGCZ. Three biological replicas from the excised muscle of the operated side (sample END) and its contralateral control (sample END-CC) from the CONTROL, N6W and N22W group 6 weeks after repair were analyzed. In brief, 5 mg of muscle tissue was cryosectioned, compounds extracted in cold MetOH: MTBE: H20 = 360: 1200: 348 using a full glass Potter type homogenisator and 10ul of LysoPC (17:0; Avanti Polar Lipids, Inc. Sigma) and 13 C-Sorbitol (Sigma) was added as internal standards.
The upper (non-polar) phase was recovered after a centrifugation step (5 min at 1000g, at 4 C), collected and stored at À30 C. All extraction steps were carried out in dichlormethane-rinsed Duran glassware using MS-Grade compounds (CHROMOSOLV 1 , Sigma 
Transcript expression
Total RNA was isolated from three biological replicas for all time points (PRE, TR, END and END-CC) of the CONTROL, N22W and N6W group as described [33] and selected samples were subjected to RNA sequencing using standard protocols. In brief, an approximate of 15 mm3 of cryosections was pooled and processed using the RNeasy kit (Qiagen). The volume of the sectioned tissue was estimated based on the cross-sectional area, as measured with a ruler for representative sections on slides under a microscope, the thickness and the number of pooled sections. The quantity and quality of total RNA were evaluated using Qubit 1 RNA BR Assay Kit (LifeTechnologies, USA) and Agilent RNA 6000 Nano kit with the Agilent 2100 Bioanalyzer instrument (Agilent Technologies Inc., Santa Clara, USA), respectively. RNA sample was accepted for the study when the RIN was !7.0.
Library products were generated from 1 mg total RNA subsequent to the removal of ribosomal RNA with the Epicentre RiboZero TM Magnetic Gold Kit and fragmentation of the enriched RNA using the Illumina TruSeq 1 Stranded total RNA protocol. Subsequently first strand cDNA synthesis was carried out using random hexamers, followed by removal of the RNA template and second strand cDNA synthesis in the presence of dUTP in place of dTTP. Next, the 3 0 ends of the blunt fragments were adenylated, multiple indexing adapters ligated, the cDNA amplified using PCR and the quantity and quality of generated libraries determined by qPCR with Illumina adapter specific primers using the Roche LightCycler 1 system (Roche Diagnostics, Basel, Switzerland) and an Agilent Technologies 2100 Bioanalyzer with a DNA-specific chip, respectively. Diluted libraries (10 nM) were pooled, used for cluster generation according to the manufacturer's recommendations using TruSeq SR Cluster Kit v3-cBot-HS reagents and sequenced with TruSeq SBS Kit v3-HS reagents on Illumina HiSeq 2500 in the high output mode. On average 50 0 000 0 000 reads were sequenced per library. Raw reads were cleaned by removing adapter sequences and by trimming the first three and last four bases.
The resulting high-quality reads were aligned to the current genome build (Oar_v3.1.75, Ensembl) using STAR (v2.3.0e) [34] . The resulting mapping rate was 90%. Approximately 55% of the reads corresponded to mRNA. Counting was performed using the countOverlaps-method from the IRanges package in Bioconductor (v2.13 with R 3.0.2). Raw signals were expressed as 'normalized signals', reflecting the frequency of the individual gene transcripts. Subsequently the 'relative concentration' of gene transcripts was estimated based on the product of multiplying the 'normalized value' for each transcript with the measured 'RNA concentration' per volume of muscle tissue. Data sets were deposited under series record GSE80374 in the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ezazgo-mefzupxyf&acc=GSE80374).
Characterization of protein expression
Relative concentrations of proteins of interest per total protein were assessed essentially as described [35] . In brief, 10 mg total proteins in total homogenate from the different sample points for either intervention, for one sheep each, were loaded in adjacent lanes aside a common sheep muscle sample and a prestained molecular weight marker (#161-0374, Biorad) on one 7.5% SDS-PAGE using precast gels (Biorad Mini-protean TGX Stain-free). Proteins were separated, western blotted on nitrocellulose membrane (Schleicher & Schuell, GE Healthcare) and proteins of interest were detected by incubating the membrane with specific antibodies in 5%-milk/1% BSA ÀTTBS and enhanced chemoluminescence.
PPARG isoforms 1 and 2 were detected using 1: 1 0 000 dilution of monoclonal mouse antibody (no. LS-C178333 from LS Bio, Lifespan Biosciences Inc., LabForce AG, Nunnigen, Switzerland) and 1: 20 0 000 dilution of horse-radish peroxidase-conjugated secondary antibody (goat anti-mouse, #9917 Sigma). Androgen receptor was detected using a 1:250 dilution of rabbit pAb PG-21 (#06-680, Merck Millipore, Zug, Switzerland), respectively, and a 1:20 0 000 dilution of horse-radish peroxidase-conjugated secondary antibody against rabbit immunoglobulins (#55676, MP Biomedicals, Basel, Switzerland). The respective signals were recorded using a PXi System (Syngene, Labgene Scientific SA, Chatel St Denis, Switzerland). Recorded signal was quantified using Quantity one (Biorad, Cressier, Switzerland) with the rectangular mode. Signal was scaled relative to the common sample that was present on all blots and subsequently normalized to the mean of pooled prevalues for each blot.
Statistics
Statistical tests for muscle composition and protein expression were carried out using SPSS (version 22, IBM corporation). Effects on the operated muscle side were assessed with a repeated ANOVA for the factor 'intervention group' (CONTROL, N22W, N6W) and the repeated factor 'time point' (PRE, TR, END). Data were also compared to the results in the END-CC as revealed by a twofactorial ANOVA for the factors 'muscle side' (operated, contralateral) x 'intervention group' (CONTROL, N22W, N6W). A post hoc test for the least significant difference was deemed appropriate for localizing effects. Results were displayed using Prism (Version 5.01, GraphPad Software, Inc.). Linear relationships were assessed using Pearson correlations. A p-value < 0.05 was called significant.
'Relative concentrations' of gene transcripts were assessed using permutations of T-tests with the Significance Analysis of Microarrays test (SAM) running as an applet in Microsoft Excel software [36] . Affected gene transcripts were identified from a comparison of paired classes at a false discovery rate (FDR) of 2%, extracted using a manual process in MS-Excel (Microsoft, Kildare, Ireland) and subsequently analyzed for affected GOs with MetaCore software (GeneGo, Thompson Reuters) using the annotation from homologue human genes. GOs were considered significantly enriched if the p-value of enrichment was below the FDR and if the counts of altered transcripts for the respective GO pointed significantly in one direction based on a p-value < 0.01 for a binomial distribution ('Binomdist' function in MS-Excel). Subsequently GOs being associated with the muscle, fat and extracellular compartment were identified and extracted based on whether they contained the mesh terms: 'muscle', 'skeletal muscle' or 'fiber'; 'lipid', 'fat'; 'extracellular', 'matrix', 'connective tissue' or 'adhesion'. In case of overlap, only the parent GO was retained.
For the assessment of ion abundance, the mass spectrometry data set was limited to those compounds being detected in all analyzed samples. The total lipid signal was defined as the summed abundance of all ions being detected in one given sample. For each sample, raw signals of each compound were related to the internal LysoPC (17:0) standard. Changes were assessed based on permutations of T-tests using SAM [36] . A paired class design was applied to identify differences between the operated muscle and its contralateral control. An unpaired class design was applied to identify changes between the intervention groups for post vs. contralateral differences. A false discovery rate of 5% was deemed significant. Output was exported into MS-Excel for table assembly. For the altered species, the corresponding lipid class was manually extracted by consulting the Pubchem entry. Lipid classes were considered significantly enriched if the number of altered lipid species of the respective class pointed in one direction based on a p-value < 0.01 (Binomdistribution). Affected lipid compounds and transcripts were subjected to correlation analysis using the expression correlation network plugging of the cytoscape software (2.5.0) at a condition of r > |0.99|.
Results
Anatomic alterations
The changes after 16 weeks of tendon release in the CONTROL group included a myotendinous retraction of 5.8 + 0.5 cm and a 22% loss of muscle volume. The area percentage of muscle fibers was reduced by 30% while the area percentage of fat was increased by 281% ( Fig. 1 ), reaching together with the extracellular matrix a value corresponding to 38% of total area percentage of the muscle. Muscle alterations with tendon release were not substantially altered in the 6 weeks after repair.
Compared to CONTROL, nandrolone administration starting immediately after tendon release (N22W) prevented the increase in area percentage of fat (23% vs. 277% and À1% vs. 398%, respectively) and mitigated the reduction in area percentage of muscle fibers after tendon release (12% vs. 30% and 16% vs. 35%, respectively), as well as repair (Fig. 1) . The area percentage of the extracellular matrix was increased by 368% after 16 weeks of tendon release under nandrolone administration and tended to be different from the not-significantly affected values in the CONTROL group (p = 0.06). The administration of nandrolone for 6 weeks starting with tendon repair (N6W) did not affect the changes in muscle volume (À23% vs. À31%) and muscle composition (muscle fiber area: À44% vs. À35%; lipid: 1260& vs. 398%, extracellular matrix: 260% vs. 240%) as seen in the CONTROL group with tendon release and repair.
Metabolic alterations
703 lipid species were detected in the infraspinatus muscle (Fig. 2) . The pool sizes of 227 lipid species in the CONTROL group were increased after tendon release and 6 weeks of repair compared with the non-operated contralateral control. The changes concerned the lipid class of fatty acyls, phospholipids, prenol lipids, polyketides, sterol lipids and sphingolipids but not glycolipids (Table 1 ).
In the N6W group, 185 of the 227 lipid species in the CONTROL group were increased after tendon release and repair compared with the contralateral control ( Table 1 ). In the N22W group, the administration of nandrolone starting immediately after tendon release mitigated the increase of lipid species in the operated muscle ( Table 2 , Fig. 2 ). In consequence, in this group no lipid species was increased after tendon release and repair.
Expression of androgen receptor and the adipocyte differentiation marker PPARG
Protein levels of isoform 2 (PPARG2) but not isoform 1 (PPARG1) were increased 16 weeks after tendon release, in all the three intervention groups (Fig. 3A-C) . Neither of the PPARG isoforms was affected by nandrolone.
Mean protein levels of the androgen receptor were not affected 16 weeks after tendon release in the CONTROL group but increased 5-fold 6 weeks after repair (Fig. 3D/E) . Androgen receptor levels were increased 6-fold after tendon release under nandrolone administration in the N22W group and remained at an elevated level after repair. In the N6W group, nandrolone administration after repair increased androgen receptor levels above the level alterations seen after 16 weeks of tendon release but this did not differ to the effects seen in the CONTROL group.
RNA concentration with tendon release, repair and nandrolone administration
RNA concentration per muscle volume was not altered 16 weeks after tendon release, or 6 weeks after repair in the CONTROL group (Fig. 4) . Nandrolone administration starting after tendon release (in the N22W group) increased RNA concentration by 67% at tendon repair (Fig. 4) before RNA concentration decreased below pre-levels 6 weeks after repair. Nandrolone administration starting Table 1 Alterations in lipids after tendon release and repair. Number of significantly affected lipid species in the non-polar fraction (SAM, FDR = 5%), median fold changes per lipid class and the p-value for the change over the entire lipid class, respectively, in sheep infraspinatus muscle 16 weeks after tendon release and 6 weeks after repair (END) versus contralateral controls (END-CC) in the CONTROL and N6W group, respectively (n = 3). Values were calculated based on raw signals of each compound relative to the internal standard LysoPC (17:0). Fig. 3 . Protein levels of adipocyte marker PPARG and androgen receptor. A, D) Representative example of immunoblots showing the abundance of PPARG isoforms and androgen receptor in infraspinatus muscle prior to tendon release (PRE), at repair (TR) PRE) and 6 weeks after repair (END) in the CONTROL, N6W and N22W groups. The dividing line illustrates how the records from different blots were assembled. B, C, E) Whisker plots visualizing the median, 25% and 75% confidence interval (central line and borders of box) and minima/maxima (extremes of the lines) of the protein abundance for the PPARG1 and PPARG2 isoforms, and androgen receptor. *P < 0.05, **P < 0.01 or ***P < 0.005 vs. PRE; +P < 0.05 or ++P < 0.01 vs. TR, #P < 0.05 or ##P < 0.01 vs. CONTROL. Repeated-measures ANOVA with post-hoc test of Fisher. N = 6 per group.
after repair (in the N6W group) tended to increase the RNA concentration by 40%.
Global alterations in transcript expression with tendon release
13821 gene transcripts were expressed in infraspinatus muscle (the transcriptome). In the CONTROL group, tendon release affected the muscle transcriptome in a specific pattern and this was further modified with the subsequent repair (Fig. 5A) . The relative concentration of 1397 transcripts was influenced 16 weeks after tendon release: 945 transcripts were down-regulated 16 weeks after tendon release, emphasizing an enriched affection of GOs being associated with muscle, and contrary to our expectation, fat (Fig. 5B, Table 3 , Table S1 ). 452 transcripts were up-regulated after tendon release; being enriched for GOs that are associated with muscle fibers, the extracellular matrix, the vasculature and nerves. The highest significance for enrichment concerned the GO of 'extracellular structure organization' which transcripts were upregulated (Table S1 and S2). A few transcripts being associated with adipocyte differentiation (i.e. ACSM1, ADIPOQ, FABP4, PLIN1, PPARG2) and two extracellular factors, only, associated with dedifferentiation of fibroblasts (i.e. FAP, DPP; [37] , were increased 16 weeks after tendon release but the corresponding GO was not significantly affected.
Tendon repair produced qualitative alterations in the expression pattern of transcripts being associated with contraction, mitochondrial metabolism and protein translation (Fig. 5A) . At the selected threshold of statistical significance (FDR of 2%), none of the measured transcripts changed in concentration 6 weeks after repair compared to the situation after tendon release.
Anabolic steroid stimulates transcript expression
Compared to the response in the CONTROL group, the concentration of 1994 gene transcripts was increased at repair with nandrolone administration (in the N22W group) starting with tendon release. The major theme was the up-regulation of GOs associated with the extracellular matrix and neurogenesis. As well GOs associated with skeletal muscle and the catabolism and biosynthesis of lipids were up-regulated ( Fig. 5B ; Table S3 ). The concentration of thirteen transcripts being associated with adipocyte differentiation was increased at repair with nandrolone administration during the 16 weeks after tendon release, but this did not include PPARG2.
Nandrolone administration starting with repair (in the N6W group) modified the response of 10756 gene transcripts; 273 being increased and 10483 being reduced 6 weeks after repair compared to the response of the CONTROL group. This response of the N6W group differed to the response of the N22W group to nandrolone administration during the 16 weeks after tendon release (Fig. 6A) . 1722 transcripts, which were increased at repair in the N22W group compared to the CONTROL group, were down-regulated in the N6W group with nandrolone administration during the 6 weeks of repair (Fig. 5A) . 272 transcripts were similarly upregulated in both the N6W and N22W group; the majority of which was associated with neurogenesis (Table S4 ). All gene ontologies, which reflected the altered gene transcripts, demonstrated altered responsiveness to nandrolone administration in function of whether nandrolone was administered during the 16 weeks after tendon release (N22W group) or only during the 6 weeks after repair (N6W group; Fig. 6B ). This included 37 gene ontologies being involved in lipid metabolism, muscle contraction, adhesion and angiogenesis (Table S3 ).
Interdependencies
Network analysis of the correlations between fold changes in gene transcripts and lipid compounds over all three interventions identified 3 major entities which described linear relationships within the class of lipid compounds and gene transcripts, but not between them (Fig. 7) .
Discussion
Synopsis
The prevention of muscle transformation including fiber atrophy, fat accumulation, and matrix increases is a priority for successful repair of rotator cuff tendons (reviewed in [4, 38] ). We recently demonstrated that the early administration of nandrolone is a possible measure against the accumulation of intramuscular fat with tendon release of rotator cuff muscle in sheep [11] . The fat mobilizing effect of nandrolone has been explained by alterations in the handling of liver-derived high-density lipoprotein cholesterol [7, 39] . To our knowledge, except for altered expression of the lipoprotein apolipoprotein D, it is not known whether nandrolone exerts direct effects on lipid metabolism in skeletal muscle [14, 40] . In order to resolve the underlying mechanism, we applied a combination of high-throughput molecular measurements and morphometric analysis in an established sheep model for tendon tears of rotator cuff muscle. The results provide first evidence that nandrolone administration reduces the wasting of muscle fibers (Fig. 1G) and exerts a global influence on transcript and lipid expression in the released infraspinatus muscle. The effect of nandrolone on the transcriptome differed from the alterations when nandrolone was administered after repair and this was related to protein levels of the androgen receptor.
Limitations
A number of factors may be considered when valuing our data. First, no time point assessed the early adaptations with tendon release and the injection of the anabolic steroid. Therefore possibly important first molecular adjustments of muscle to tendon release, which regulate adipogenesis [41] , are missed. However the study of the early responses to tendon release were not an option for the current investigation as the focus was on testing the effect of nandrolone administration on lipid accumulation and confirming the reduced effect of nandrolone administration in retracted muscle. Importantly, the injections of the steroid were provided weekly and prevented the elevation of fat content at the earliest selected time point of measurement, 16 weeks after tendon release after which lipid content only tended to increase during repair (p = 0.11; Fig. 1H ). Therefore one would expect that transcript expression of processes, which underlie adipocyte differentiation (or proliferation), lipid biosynthesis and lipid storage, would be specifically lowered in 16 weeks released muscles with nandrolone administration. Secondly, metabolic measurements outside the muscle compartment were not part of our experiment because the focus of our investigation was put on the contribution of local mechanisms to fatty infiltration and atrophy of rotator cuff muscle with tendon release and the altered responsiveness to nandrolone. Nonetheless, we believe that the present novel observations apprehend the understanding of the nandrolone-induced mitigation of fatty infiltration and atrophy of the released rotator cuff muscle and the loss of this response when administration starts after fatty atrophy has been established.
Overview of alterations across biological layers
The comparison of the changes in muscle composition and transcript expression 16 weeks after tendon release revealed that these did correspond for factors being associated with muscle fibers and the extracellular matrix. For instance the downregulation of GOs associated with muscle contraction did coincide with the reduction in the area percentage of muscle fibers Transcript data were log-transformed, mean-centered for genes and subjected to centered cluster analysis for genes and arrays. Three biological replicas were assessed per condition. Transcript levels are given in color-coding (up: red; down: blue) and are ordered according to the correlation of their response in clusters as indicated in the dendrogram. Specific gene ontologies of interest are indicated with arrows and brackets. B) Sketch of the main GOs, reflecting muscle processes and compartments, which were affected 16 weeks after tendon release without (CONTROL) or with nandrolone administration. Number in brackets refers to the counts of affected transcripts (increased/decreased) for the respective GO. GOs shown in grey font were not significantly affected in a specific direction. The influence of nandrolone on fold changes with tendon release is indicated in black boxes and arrows. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) (compare Table S1 with Fig. 1G and Fig. 5B ). Similarly the upregulation of GOs associated with the extracellular matrix matched the increase in area percentage changes of the extracellular matrix compartment (compare Table S1 with Fig. 1I and Fig. 5B ). In contrast, changes in the lipidome and lipid area percentage after tendon release (and repair) were not reflected by co-directional level alterations in transcripts being related to lipid metabolism (compare Fig. 1H and Fig. 5B ). For instance tendon release and repair elevated the pool size of phospholipids, cholesterols and fatty acyls consistent with reported alterations of lipid classes in Table 3 Gene ontologies demonstrating altered responsiveness to nandrolone when administered after tendon release. Counts, and p-values of the changes with nandrolone administration in the respective group for gene ontologies which transcripts demonstrated significant opposite regulation with nandrolone administration respective to CONTROL during the response to tendon release (N22W) or during the response to repair (N6W). rabbit muscle after 1-2 weeks of tenotomy [24] and the lipid composition of adipocytes [42] . However, GOs associated with lipid biosynthesis were lowered 16 weeks after tendon release (at repair) and only few transcripts related to adipocyte differentiation were increased (Fig. 5B) . Aside isoform 1 and 2 of the adipocyte differentiation marker PPARG, this included a 10-fold increase in negative (adiponectin; ADIPOQ, adipocyte enhancer binding protein 1; AEBP1) and positive regulators of adipogenesis (adipogenesis regulatory factor; ADIRF), the factor of fatty acid uptake and transport in adipocytes, fatty acid binding protein 4 (FABP4), and acyl-CoA synthetase medium-chain family member 1 (ACSM1). Other established markers of fat cell differentiation [43, 44] that are increasingly expressed in rotator cuff muscle after tendon release, such as sterol regulatory element-binding protein 1 (SREBP1) and CCAAT/enhancer binding protein beta (C/EBPb) [16, 18] , were not affected at the transcript level (data not shown). An up-regulation of lipid-associated gene transcripts, including PPARG, has been observed between 30 days and 16 weeks of tenotomy [18, 41, 45] . We corroborate this observation at the protein level by showing increased PPARG2 protein levels after 16 weeks of tendon release (Fig. 3A-C) . Our findings support previous results in the rat, showing that fat accumulation with release of the rotator cuff tendon does not occur by activation of the canonical intramyocellular lipid storage and synthesis pathways [45] but does involve expressional up-regulation of specific pro-adipogenic factors.
Nandrolone and transcript regulation related to lipid biosynthesis
In contrast to the expectation from the lowered abundance of 243 lipid species (Table 2) , nandrolone administration upregulated transcript level for factors of fat cell differentiation and lipid biogenesis (Fig. 5B) . For instance expression of transcripts being associated with central aspects of adipocyte differentiation (PPARG2; [46, 47] and the maturation of lipid droplets (perilipin 1; PLIN1, vimentin, VIM) and FABP4 [48, 49] remained unaffected by nandrolone, i.e. it remained elevated at TR in the N22W group. We have shown previously that fat cell accumulation in infraspinatus muscle of sheep continues beyond 16 weeks of tendon release [3] . Collectively this implies that the prevention of fat accumulation in released infraspinatus muscle is not explained by a block of adipocyte differentiation, transcriptional down-regulated of lipid biosynthesis or lipid oxidation. Likely candidate explanations contributing to the nandrolone-mediated suppression of lipid biosynthesis, include the post-translational regulation of lipid biosynthesis in infraspinatus muscle or processes external to the studied muscle that control the delivery and import of substrates for lipid synthesis [7, 39] .
Nandrolone and androgen receptor expression
Our findings show that nandrolone administration with tendon release did up-regulate anabolic receptor protein and total RNA concentration in infraspinatus muscle of sheep (Fig. 3D/E, Fig. 4 ). This observation is consistent with previous findings on the effect of anabolic steroid on androgen receptor levels in mice, rat and humans [28, 29, 40, 50] . Our findings show that nandrolone upregulated transcripts of muscle-associated gene ontologies in line with a mitigated reduction of the area percentage in muscle fibers (Fig. 1G ). This included prominent factors associated with contraction such as troponin C and I, myosin regulatory light chain and actinin, as well as myoglobin. We interpret our findings to indicate that the nandrolone-induced increase in androgen receptor levels are part of a feed forward mechanism that promotes the genomic effect of androgen signalling on protein metabolism in muscle fibers.
Tendon release affects the transcript response to nandrolone
Intriguingly, the absent effect of nandrolone on lipid accumulation when administration started after repair (N6W) was related to the inversion of the global transcript response compared to the N22W group when nandrolone was given for the duration of release (Fig. 6 ). This result emphasized the reduced responsiveness of degenerated rotator cuff muscle to stimulation by nandrolone [30] . As well it was found that androgen receptor levels were not modified compared to the CONTROL group in the N6W group (Fig. 3E ). These observations suggest that the reduced responsiveness of degenerated rotator cuff muscle to nandrolone is related to a down-regulation of the genomic response to anabolic steroid. In this regard it is of interest that androgen receptor density in rat skeletal muscle is increased by contractile activity and decreased by steroid treatment [51] . The unaffected androgen receptor levels in the N6W group imply that this disparity of effect involves adjustments in the capacity for androgen receptor mediated signalling in skeletal muscle.
Relationship between the nandrolone-modulated muscle metabolome and transcriptome
A considerable portion of the lipid species, of which an increased pool size after tenotomy was prevented by nandrolone, are found in plasma membranes, i.e. glycerolipid, phospholipid, prenol lipid, sphingolipid, sterol lipid. Nandrolone has been shown before to acutely affect the plasma membrane of many cell types during its cell entry, i.e. by exerting electrophysiological actions [52] and influencing lipid peroxidation [53] . The present novel observations raise the possibility that the mitigating effect of nandrolone on lipid accumulation in tenotomised infraspinatus muscle also involves direct effects on plasma membrane integrity. Network analysis (Fig. 7) identifies an important number of linear relationships within the class of lipid compounds, and gene transcripts, including those being associated with the regulation of lipid metabolism, but not between them. The role of affected plasma membrane species in respect to the changes in transcript expression following the early administration of the synthetic lipid compound, nandrolone, remains to be tested.
Clinical relevance
Our results provide a number of clinically relevant conclusions. The nandrolone-and repair-regulated concentration of the androgen receptor levels and downstream effects on transcript expression in infraspinatus muscle provides a signpost when the treatment effects are to be expected. The findings thereby emphasize that the specific importance of muscle activity regulated androgen receptor expression lies in the modulation of the effects of nandrolone on muscle fat content [29, 51] . As well we noted that elevated protein expression of PPARG2 after 16 weeks of tendon release resisted to nandrolone administration. This suggests that differentiation of adipocytes in released rotator cuff muscle may be irreversibly enhanced within the investigated time frame. As well we noted an important up-regulation of transcripts for adhesive processes, which are a prerequisite for adipocyte differentiation [44, 54, 55] , with tendon release and this was further enhanced by nandrolone. This evidence for an enhanced presence of gene messages for pro-adipogenic processes bears the question for how long the released infraspinatus muscle is protected from lipid accumulation once nandrolone administration is discontinued. Finally, we identify at the level of statistical significance that nandrolone also reduces the loss in muscle fiber area percentage; supporting that nandrolone administration immediately after tendon release preserves muscle quality by avoiding the degeneration of contractile material.
Conclusion
Our molecular observations imply that the lost responsiveness of retracted rotator cuff muscle to anabolic steroid in lowering the pools sizes of lipid compounds is associated with defective, genomic actions of nandrolone, as reflected by a general downregulation of transcript expression. Conversely, the prevention of lipid synthesis in sheep infraspinatus muscle with nandrolone administration starting immediately after tendon release is associated with up-regulated androgen receptor protein and RNA expression. Resistance of the adipocyte marker PPARG to regulation by nandrolone, indicates that prevention of fat accumulation in retracting rotator cuff muscle by nandrolone administration is not mediated by the suppression of adipocyte differentiation.
